Platelet-Released Growth Factors Modulate the Secretion of Cytokines in Synoviocytes Under Inflammatory Joint Disease
January 2017
in “
Mediators of Inflammation
”
TLDR Platelet-released growth factors can reduce inflammation in joint disease.
The study examined the effects of platelet-released growth factors (PRGF) on synoviocytes in an in vitro model of inflammatory arthritis, using 9 samples for cytokine release experiments. PRGF was found to reduce the expression of inflammatory cytokines such as TNF-α, IL-6, and IL-1β, while increasing anti-inflammatory cytokines like IL-10 and VEGF. This suggested PRGF's potential as an anti-inflammatory treatment for conditions like rheumatoid arthritis. The study noted variability in PRGF effectiveness based on cell types and tissue vascularization, with lower concentrations being more effective in less vascularized tissues. Although promising, the study recommended further research using primary cells from rheumatoid arthritis patients to better understand the mechanisms involved.